Oscient Pharmaceuticals Corp. (OSCI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oscient Pharmaceuticals Corp. (OSCI)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Tara Cobble who wrote (78)	9/18/1996 10:11:00 AM
From: Peter Shaw	of 1154

Tara, What draws me to GENE is they are one of the elite few companies making money right now. It's a solid base from which to expand, since they don't need to continously dilute shares to stay afloat. Plus genomics is where the major new discoveries will come from (a biotech researcher friend of mine confirmed this huge potential). ARRS looks like a very speculative stock, and since the trading range is flattish, you need to have faith in their abilities over the long haul. The tech analysis probably won't make you alot of money in the short to mid term. ARNX looked a little more interesting. Again, all speculation, but they were in late phase II/phaseIII trials on one of their products. Keep your eye on those developments. I try to keep tech analysis to the bare essentials,but feel like I can read a bullish trend pretty well. Of the 3, GENE looks like it has the volatility to push the price much higher than the others. Combined with the fundamentals, it's my pick of the 3 :-> Check out RZYM if you like to speculate on this category. Looks like a long term winner. Cheers, Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next